Literature DB >> 28785329

Interdigital Melanoma of the Foot Affecting Two Neighbouring Interdigital Spaces - Second Case Report.

Uwe Wollina1, Carsten Rilke2, Gesina Hansel1, Dana Langer1, Jacqueline Schönlebe3, Georgi Tchernev4.   

Abstract

Melanoma affecting two interdigital spaces has been recently described by our group for the first time in medical literature. Here we present a second patient with acrolentiginous melanoma of the sole affecting the 1st and 2nd interdigital space. The tumour was removed by delayed Mohs surgery. Due to the extension of the melanoma, digit II and III had to be removed. Staging excluded metastatic spread. The tumour was classified as pT4bN0M0.

Entities:  

Keywords:  Melanoma; Mohs surgery; acrolentiginous melanoma; interdigital spaces; staging

Year:  2017        PMID: 28785329      PMCID: PMC5535654          DOI: 10.3889/oamjms.2017.112

Source DB:  PubMed          Journal:  Open Access Maced J Med Sci        ISSN: 1857-9655


Introduction

Acrolentiginous melanoma (ALM) is an uncommon subtype in Caucasians. It is considered as a tumour with an unfavourable prognosis, mainly because of delayed diagnosis. In the German population, ALM patients are significantly older than the average of melanoma patients and the most common localisation is plantar [1]. Subungual ALM often is diagnosed in an advanced stage that needs functional amputation [2]. The preferred site of metastasis in ALM is bone [3]. In the case of primary misdiagnosis of ALM, the prognosis becomes even worse due to the delay of appropriate treatment [4, 5]. Recently, the first case of ALM involving two neighbouring interdigital spaces has been reported by Tchernev et al. (2017) [6]. Here, we report another case of this unusual presentation of ALM. Case report A 90-year-old female patient presented with a slow-growing lesion of the left foot pad which was easily bleeding for a couple of weeks. Her medical history was positive for diabetes mellitus type 2, pulmonary hypertension, arterial hypertension and hyperlipidemia. In 2009, she was diagnosed with colon cancer, and a hemicolectomy had been performed. She had a cataract surgery on her left eye in 2010. On examination, we observed a 15 x 10 mm large, partially ulcerated tumour on the plantar skin with the involvement of interdigital spaces II and III and digits II and III (Fig. 1a). We performed diagnostic biopsies. Histologic examination revealed a largely amelanotic ALM with numerous MART-1 and Ki67-positive cells (Fig. 2).
Figure 1

Amelanotic acrolentiginous melanoma involving two interdigital spaces. (a) Clinical presentation; (b) and (c) After first Mohs session; (d) Surgical specimen

Figure 2

Histopathology of amelanotic acrolentiginous melanoma. (a) Overview and (b) detail of an amelanotic epitheloid cell proliferation in the mid dermis and increased number of melanocytic cells in the basal cell layer of the epidermis (Hematoxylin-eosin x 2 and x 4, respectively). Immunoperoxidase stain for MART-1 demonstrating numerous positive tumour cells (x4)

Amelanotic acrolentiginous melanoma involving two interdigital spaces. (a) Clinical presentation; (b) and (c) After first Mohs session; (d) Surgical specimen Histopathology of amelanotic acrolentiginous melanoma. (a) Overview and (b) detail of an amelanotic epitheloid cell proliferation in the mid dermis and increased number of melanocytic cells in the basal cell layer of the epidermis (Hematoxylin-eosin x 2 and x 4, respectively). Immunoperoxidase stain for MART-1 demonstrating numerous positive tumour cells (x4) We decided to perform complete surgical removal by delayed Mohs technique (Fig. 1b-d). Histologic examination of the specimen confirmed the diagnosis of ALM, tumour thickness, Clark level. The first Mohs session was successful in removing the tumour but margins were positive for melanoma in situ component. The histologic investigation revealed a tumour thickness of 6.8 mm with Clark’s level V. In a second session, we achieved a complete resection with free margins, but digits II and III had to be sacrificed. After careful hemostasis, the wound was sutured (Fig. 3). Antibiotic prophylaxis with oral ciprofloxacin has been performed. A forefoot offloading shoe was prescribed to ensure undisturbed complete wound healing.
Figure 3

Second Mohs session. (a) After resection of digit II and II; (b) Resection specimen; (c) After suturing

Second Mohs session. (a) After resection of digit II and II; (b) Resection specimen; (c) After suturing Staging with diagnostic ultrasound of lymph nodes and abdomen, and X-ray of lungs and the right foot did not show any signs of metastatic spread. Laboratory investigations: S100 0.113 µg/l (normal range < 0.125), lactate dehydrogenase 4.49 µkat/l (2.25-3.55), uric acid 397 µmol/l (140-340), creatinine 90 µmol/l (< 80), cholesterol 7.12 mmol/l (< 5.2), HbA1C 56 mmol/ml (20-42), neutrophils 0.20 Gpt/l (1.8-7.6), monocytes 5.90 Gpt/l (0-1.0). Due to the patient’s age, we decided to run a wait and see the strategy.

Discussion

In Germany, the number of annually documented melanoma cases increased by 53.2% between 2002 and 2011 with a statistically significant positive trend in the proportion of thin melanomas (stage UICC I). The overall 5-year relative survival for melanoma was estimated between 83.4% and 89.4% [7,8]. ALM is an uncommon tumour type with an unfavourable prognosis [9]. Ulceration was present in 38.6% of ALM, and average tumour thickness reached 3.5 mm in a study from Barcelona [10]. Patients with ALM are usually older that the non-ALM melanoma patients and the tumour size are larger at the time of diagnosis [11]. Also, ALM show distinct features of mutations. Comprehensive genomic and transcriptomic analysis of 34 ALM patients demonstrated the absence of UV-derived mutation signatures. PAK1 copy gains and somatic TERT mutations or germline events were detected in 41% of patients [12]. We present a peculiar, rare presentation of ALM of the foot pad with the involvement of two neighboring interdigital spaces that have been reported before only once [6]. We consider such a clinical presentation as a sign of an advanced tumour stage. The treatment of choice is complete surgical excision. In the case of thick ALM, a safety margin of 2 cm is recommended to decrease the risk of local recurrence, while disease-free survival and melanoma-specific survival were not improved [13]. To achieve a complete tumour resection amputation is not always preventable – as shown in our patient [2].
  13 in total

1.  Assessment of melanoma histotypes and associated patient related factors: basis for a predictive statistical model.

Authors:  Holger A Haenssle; Saskia Hoffmann; Timo Buhl; Steffen Emmert; Michael P Schön; Hans Peter Bertsch; Albert Rosenberger
Journal:  J Dtsch Dermatol Ges       Date:  2015-01       Impact factor: 5.584

2.  Subungual acrolentiginous amelanotic melanoma treated with amputation of the distal and middle phalanges.

Authors:  Claudio Guarneri; Valentina Bevelacqua; Kristina Semkova; Georgi Tchernev; Sven Tempel; Uwe Wollina
Journal:  Wien Med Wochenschr       Date:  2013-04-17

3.  Surgical excision margin for primary acral melanoma.

Authors:  Kyeong-Tae Lee; Eun-Ji Kim; Dong-Youn Lee; Jung-Han Kim; Kee-Taek Jang; Goo-Hyun Mun
Journal:  J Surg Oncol       Date:  2016-09-19       Impact factor: 3.454

4.  Survival from common and rare cancers in Germany in the early 21st century.

Authors:  E Hiripi; A Gondos; K Emrich; B Holleczek; A Katalinic; S Luttmann; E Sirri; H Brenner
Journal:  Ann Oncol       Date:  2011-05-19       Impact factor: 32.976

5.  Melanoma of the heel – a case series of a rare melanoma subtype.

Authors:  U Wollina; G Tchernev; A A Chokoeva; T Lotti
Journal:  J Biol Regul Homeost Agents       Date:  2015 Jan-Mar       Impact factor: 1.711

6.  Interdigital melanoma simultaneously affecting two neighboring interdigital spaces : First description in the medical literature.

Authors:  Georgi Tchernev; Ilia Lozev; Ivan Pidakev; Hristo Mangarov; Yavor Grigorov; José Carlos Cardoso; Elisaveta Popchristova; James W Patterson; Torello Lotti; Georgi Pehlivanov; Cristiana Voicu; Victor Gabriel Clatici; Uwe Wollina
Journal:  Wien Med Wochenschr       Date:  2017-04-24

7.  Clinical implications of distinct metastasizing preferences of different melanoma subtypes.

Authors:  Nicola L Schoenewolf; Benedetta Belloni; Mathew Simcock; Sabina Tonolla; Pascale Vogt; Ellen Scherrer; David Holzmann; Reinhard Dummer
Journal:  Eur J Dermatol       Date:  2014 Mar-Apr       Impact factor: 3.328

Review 8.  Acral Lentiginous Melanoma.

Authors:  James S Goydos; Steven L Shoen
Journal:  Cancer Treat Res       Date:  2016

9.  Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011.

Authors:  Olaf Schoffer; Stefanie Schülein; Gerlinde Arand; Hans Arnholdt; Dieter Baaske; Ralf C Bargou; Nikolaus Becker; Matthias W Beckmann; Yves Bodack; Beatrix Böhme; Tayfun Bozkurt; Regine Breitsprecher; Andre Buchali; Elke Burger; Ulrike Burger; Klaus Dommisch; Gudrun Elsner; Karin Fernschild; Ulrike Flintzer; Uwe Funke; Michael Gerken; Hubert Göbel; Norbert Grobe; Vera Gumpp; Lucie Heinzerling; Lana Raffaela Kempfer; Alexander Kiani; Monika Klinkhammer-Schalke; Sabine Klöcking; Ute Kreibich; Katrin Knabner; Peter Kuhn; Stine Lutze; Uwe Mäder; Tanja Maisel; Jan Maschke; Martin Middeke; Andreas Neubauer; Antje Niedostatek; Anabelle Opazo-Saez; Christoph Peters; Beatrice Schell; Gerhard Schenkirsch; Harald Schmalenberg; Peter Schmidt; Constanze Schneider; Birgit Schubotz; Anika Seide; Paul Strecker; Sabine Taubenheim; Matthias Wackes; Steffen Weiß; Claudia Welke; Carmen Werner; Christian Wittekind; Jörg Wulff; Heike Zettl; Stefanie J Klug
Journal:  BMC Cancer       Date:  2016-12-05       Impact factor: 4.430

10.  Integrated genomic analyses reveal frequent TERT aberrations in acral melanoma.

Authors:  Winnie S Liang; William Hendricks; Jeffrey Kiefer; Jessica Schmidt; Shobana Sekar; John Carpten; David W Craig; Jonathan Adkins; Lori Cuyugan; Zarko Manojlovic; Rebecca F Halperin; Adrienne Helland; Sara Nasser; Christophe Legendre; Laurence H Hurley; Karthigayini Sivaprakasam; Douglas B Johnson; Holly Crandall; Klaus J Busam; Victoria Zismann; Valerie Deluca; Jeeyun Lee; Aleksandar Sekulic; Charlotte E Ariyan; Jeffrey Sosman; Jeffrey Trent
Journal:  Genome Res       Date:  2017-04       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.